From Health to Welfare

Understanding the Complex Interactions Between Interventions, Well-Being, and Resource Allocation

Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector

Values Beyond “Health” in Budget-Constrained Healthcare Systems

Subjective Well-Being Population Norms and Inequalities in Hungary: A Large Cross-Sectional, Internet-Based Survey

A Head-to-Head Comparison of EQ-HWB and EQ-5D-5L in Patients, Carers, and General Public in China

From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year

Construct Validity, Reliability, and Responsiveness of the 10-Item Well-Being Instrument for Use in Economic Evaluation Studies

 

Rare Diseases: Economic Evaluation and Policy Considerations

Rare Diseases: Economic Evaluation and Policy Considerations

Toward Patient-Centered Drug Approval for Treatment of Rare Diseases

Discriminatory Properties of the Quality-Adjusted Life Year Based Cost-Effectiveness Analyses for Patients With Disabilities: A Duchenne Muscular Dystrophy Case Study

Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism

The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs

Evidence Quality and Health Technology Assessment Outcomes in Reappraisals of Drugs for Rare Diseases in Germany

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×